Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Q3 2022 Bio Rad Laboratories Inc Earnings Call Transcript

Oct 27, 2022 / 09:00PM GMT
Release Date Price: $385.02 (-2.31%)
Operator

Good evening, and thank you for attending today's Bio-Rad Laboratories 2022 Earnings Results Conference Call. My name is Daniel, and I will be your moderator for today's call. (Operator Instructions) I would now like to pass the conference over to our host, Edward Chung, Head of Investor Relations of Bio-Rad. Edward, please proceed.

Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Thanks, Daniel. Good afternoon, and thank you all for joining us.

Today, we will review the third quarter 2022 financial results and provide an update on key business trends for Bio-Rad.

On the call with me today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I'd like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot